These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8438459)

  • 1. Rapamycin effects on immunologic reconstitution.
    Vogelsang GB; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of cyclosporin-A and rapamycin on in vivo thymocyte maturation.
    Homma M; Damoiseaux JG; van Breda Vriesman PJ
    Transplant Proc; 1997 May; 29(3):1743-4. PubMed ID: 9142256
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Route of administration determines the efficacy of rapamycin but not the mechanisms of tolerance induced by it in rats.
    Lin Y; Rutgeerts O; Waer M
    Transplant Proc; 1996 Dec; 28(6):3057. PubMed ID: 8962185
    [No Abstract]   [Full Text] [Related]  

  • 5. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.
    Severino ME; Laulis MK; Horwitz LR; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):520-3. PubMed ID: 8438399
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of rapamycin after syngeneic bone marrow transplantation in irradiated mice.
    Quesniaux V; Gibbons H; Maurer C; Stirnimann R; Wehrli S
    Transplant Proc; 1996 Dec; 28(6):3065-71. PubMed ID: 8962188
    [No Abstract]   [Full Text] [Related]  

  • 9. The antimicrobial activities of cyclosporine, FK506, and rapamycin.
    High KP
    Transplantation; 1994 Jun; 57(12):1689-700. PubMed ID: 7517076
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.
    Mohacsi PJ; Joshi A; Wang J; Morris RE; Billingham ME
    Transplant Proc; 1994 Dec; 26(6):3255-9. PubMed ID: 7998133
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation.
    Hess AD; Fischer AC; Horwitz LR; Bright EC; Hess JM
    Transplant Proc; 1995 Feb; 27(1):1370-3. PubMed ID: 7878915
    [No Abstract]   [Full Text] [Related]  

  • 12. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery.
    Tian L; Lu L; Yuan Z; Lamb JR; Tam PK
    Transplantation; 2004 Jan; 77(2):183-9. PubMed ID: 14742978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA; Wood ML; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract]   [Full Text] [Related]  

  • 14. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
    Chong AS; Gebel H; Finnegan A; Petraitis EE; Jiang XL; Sankary HN; Foster P; Williams JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):747-9. PubMed ID: 8438466
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat.
    Damoiseaux JG; Beijleveld LJ; Schuurman HJ; van Breda Vriesman PJ
    Transplantation; 1996 Oct; 62(7):994-1001. PubMed ID: 8878395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens.
    Propper DJ; Woo J; Macleod AM; Catto GR; Thomson AW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):673-4. PubMed ID: 7679837
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
    Markus PM; Cai X; Selvaggi G; Cooper M; Harnaha J; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3232-3. PubMed ID: 1721418
    [No Abstract]   [Full Text] [Related]  

  • 18. Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation.
    Gassmann W; von Kolszynski M; Wottge HU; Müller-Ruchholtz W
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2687-8. PubMed ID: 3079091
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of rapamycin on renal microsomal P-450 systems in the rat.
    Yoshimura R; Yoshimura N; Ohyama A; Tsujino T; Kusunose E; Nakatani T; Kahan BD; Stepkowski SM; Kishimoto T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):750-1. PubMed ID: 8438468
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
    Hess AD; Horwitz LR; Laulis MK
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.